Skip to Main Content

Author Details

Robert L Vessella
University of Washington
1974
341
89
PMIDPaper TitleJournal TitlePublished Year
30511964Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.J Clin Invest2019
30820039A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer.Oncogene2019
29267025Plasma Fatty Acids as Surrogate for Prostate Levels.Nutr Cancer2018
30073676Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.Prostate2018
27993966Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts.Clin Cancer Res2017
28364014Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models.Clin Cancer Res2017
28156002LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.Prostate2017
29017058Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.Cancer Cell2017
28055971Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures.Oncotarget2017
27074291Amplification of the 9p13.3 chromosomal region in prostate cancer.Genes Chromosomes Cancer2016
26489605The biology and clinical implications of prostate cancer dormancy and metastasis.J Mol Med (Berl)2016
26585210Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancer.Prostate2016
26607774High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer.J Mol Diagn2016
26667932Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.Clin Exp Metastasis2016
27641331Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.Oncogene2016
27458247GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models.Clin Cancer Res2016
26890304Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer.Epigenetics2016
26990456Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.Prostate2016
27068475Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.Cell Rep2016
26773436Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming.J Cell Physiol2016
26928463Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.Nat Med2016
27081082s-SHIP expression identifies a subset of murine basal prostate cells as neonatal stem cells.Oncotarget2016
25404182Reprogramming of prostate cancer cells--technical challenges.Curr Urol Rep2015
26246306Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.Clin Cancer Res2015
26048576A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.Cancer Immunol Res2015
26129688Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.Cancer Med2015
26071481SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.Clin Cancer Res2015
26090669Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.PLoS One2015
25634071CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.Int J Oncol2015
25749039Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.Oncotarget2015
25327986Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.Prostate2015
24242705Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.Clin Exp Metastasis2014
25287069Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.Endocr Relat Cancer2014
25255306Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer.Nat Commun2014
25198178Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes.PLoS One2014
25356728Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.PLoS One2014
25301725Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways.Oncotarget2014
24998678Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.Cancer Lett2014
24970477AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis.Cancer Res2014
24847652The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.Drug Discov Today Technol2014
24556717Androgen receptor splice variants determine taxane sensitivity in prostate cancer.Cancer Res2014
24323034Targeted androgen pathway suppression in localized prostate cancer: a pilot study.J Clin Oncol2014
22936276Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series.J Bone Miner Res2013
24353195Dietary protein restriction inhibits tumor growth in human xenograft models.Oncotarget2013
24293458Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.Oncotarget2013
24101480TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.Proc Natl Acad Sci U S A2013
24100420Tumor necrosis factor receptor associated factor-4: an adapter protein overexpressed in metastatic prostate cancer is regulated by microRNA-29a.Oncol Rep2013
24098661A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors.PLoS One2013
24205338Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling.PLoS One2013
23851165Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum.J Steroid Biochem Mol Biol2013
  • 1 - 50 of 341

Recommended Authors

Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 13
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 7
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 43
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 27
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 9
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 39
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 29
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 30
Edwin M Posadas
Cedars-Sinai Medical Center
Career Start Year 1993
Number of shared co-authors 31
Penny Flohr
The Institute of Cancer Research
Career Start Year 1993
Number of shared co-authors 30
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 13
Isla P Garraway
David Geffen School of Medicine University of California Los Angeles
Career Start Year 1993
Number of shared co-authors 29
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 6
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 9
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 10
Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1989
Number of shared co-authors 2
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 42
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 4
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 41
Eric J Small
University of California san francisco
Career Start Year 1985
Number of shared co-authors 49
Dean A Troyer
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 19
Maha Hussain
Northwestern University
Career Start Year 1984
Number of shared co-authors 44
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 52
Christopher S Foster
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 12
Simone Chevalier
McGill University Health Centre, McGill University
Career Start Year 1977
Number of shared co-authors 3
Mario A Eisenberger
Johns Hopkins University
Career Start Year 1977
Number of shared co-authors 29
Ralph Buttyan
University of British Columbia
Career Start Year 1976
Number of shared co-authors 11
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 37
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 5
Howard I Scher
Memorial Sloan Kettering Cancer Center
Career Start Year 1973
Number of shared co-authors 45

Collaborators

Eva Corey
University of Washington School of Medicine
Co-authored papers 71
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 57
Lawrence D True
University of Washington School of Medicine
Co-authored papers 56
Colm Morrissey
Co-authored papers 42
Ilsa Coleman
Fred Hutchinson Cancer Center
Co-authored papers 30
Celestia S Higano
University of Washington and Fred Hutchinson Cancer Research Center
Co-authored papers 26
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 22
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 18
Elahe A Mostaghel
University of Washington
Co-authored papers 12
Stephen R Plymate
University of Washington
Co-authored papers 12
Leroy Hood
Center for Phenomic Health, The Buck Institute for Research on Aging
Co-authored papers 9
Daniel W Lin
Co-authored papers 9
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 7
Beatrice S Knudsen
University of Utah
Co-authored papers 6
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 6
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Leena Latonen
Foundation for the Finnish Cancer Institute
Co-authored papers 5
Muneesh Tewari
University of Michigan ann arbor
Co-authored papers 5
Mark A Rubin
University of Bern
Co-authored papers 5
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 4
Camari Ferguson
Co-authored papers 4
Daniel W Chan
Division of Clinical Chemistry, Johns Hopkins University
Co-authored papers 4
Dale L Ludwig
Co-authored papers 4
Steven P Balk
Beth Israel Deaconess Medical Center and Harvard Medical School
Co-authored papers 4
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 4
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 4
Martin E Gleave
University of British Columbia
Co-authored papers 4
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 3
Jeffrey A Kiefer
Co-authored papers 3
Release 1.2